Mark Ledwidge

5.9k total citations · 1 hit paper
144 papers, 4.3k citations indexed

About

Mark Ledwidge is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Mark Ledwidge has authored 144 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Cardiology and Cardiovascular Medicine, 19 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Mark Ledwidge's work include Heart Failure Treatment and Management (65 papers), Cardiovascular Function and Risk Factors (49 papers) and Cardiac pacing and defibrillation studies (18 papers). Mark Ledwidge is often cited by papers focused on Heart Failure Treatment and Management (65 papers), Cardiovascular Function and Risk Factors (49 papers) and Cardiac pacing and defibrillation studies (18 papers). Mark Ledwidge collaborates with scholars based in Ireland, United Kingdom and United States. Mark Ledwidge's co-authors include Kenneth McDonald, Chris Watson, John A. Baugh, Christina O’Loughlin, Carmel Conlon, Dermot Phelan, J. Gallagher, Anil Patle, Ramón Martos and Mary Ryder and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Ledwidge

133 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure

2013 384 citations Mark Ledwidge, J. Gallagher et al. profile →

Peers

Countries citing papers authored by Mark Ledwidge

Since Specialization

Citations

This map shows the geographic impact of Mark Ledwidge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ledwidge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ledwidge more than expected).

Fields of papers citing papers by Mark Ledwidge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ledwidge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ledwidge. The network helps show where Mark Ledwidge may publish in the future.

Co-authorship network of co-authors of Mark Ledwidge

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ledwidge. A scholar is included among the top collaborators of Mark Ledwidge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ledwidge. Mark Ledwidge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal Adiposity and Inflammation: Risk Factors for Iron Deficiency in Pregnancy 2025 ·Journal of Nutrition ·(unknown), Maria S. Mulhern, Maeve Kerr, Mark Ledwidge, (unknown), P.D. Thompson, Mary McCann	0
2	Estimating the prevalence of potential and actionable drug‐gene interactions in Irish primary care: A cross‐sectional study 2024 ·British Journal of Clinical Pharmacology ·Laura E. Johnson, Elaney Youssef, (unknown), Tracey Thornley, Joseph Gallagher, Mark Ledwidge, Cristín Ryan	2
3	FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility 2023 ·Biomolecules ·(unknown), Hao Chen, Djurdja Jerotić, Milorad Tešić, Valentina Nikolić, Milan Pavlović, (unknown), Benjamin S. Rayner, Chris Watson, Mark Ledwidge, Kenneth McDonald, Tracy Robson, Kristine McGrath, Lana McClements	6
4	Continuous Positive Airway Pressure But Not GLP1-Mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study 2023 ·Annals of the American Thoracic Society ·(unknown), (unknown), (unknown), Brian O’Riordan, (unknown), (unknown), Kenneth McDonald, Mark Ledwidge, Donal O’Shea, David J. Murphy, Jonathan D. Dodd, Stephen J. Ryan	26
5	Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review 2022 ·The Pharmacogenomics Journal ·(unknown), Mark Ledwidge, J. Gallagher, Catherine M. Keenan, Cristín Ryan	16
6	Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need? 2021 ·PubMed ·(unknown), (unknown), M. Barrett, Carmel Halley, J. Gallagher, Mark Ledwidge, Kenneth McDonald	4
7	New-Onset Heart Failure in the STOP-HF Programme. Natriuretic Peptide Defines and Tracks Risk and Enables Earlier Diagnosis of Heart Failure 2020 ·European Journal of Heart Failure ·Sarah E. McClelland, (unknown), Eoin O’Connell, J. Gallagher, Fiona Ryan, Chris Watson, Mark Ledwidge, Kenneth McDonald	2
8	Cost-Effectiveness of Natriuretic Peptide-Based Screening and Collaborative Care: A Report from the STOP-HF (St Vincent’s Screening TO Prevent Heart Failure) Study 2015 ·European Journal of Heart Failure ·Mark Ledwidge, Eoin O’Connell, J. Gallagher, Lesley Tilson, Stephanie James, Victor Voon, Margaret Bermingham, Elaine Tallon, Chris Watson, Rory O’Hanlon, Michael Barry, Kenneth McDonald	36
9	The St Vincent's Potentially Inappropriate Medicines Study: Development of a Disease-Specific Consensus List and its Evaluation in Ambulatory Heart Failure Care 2014 ·European Journal of Heart Failure ·Margaret Bermingham, Mary Ryder, Bronagh Travers, (unknown), (unknown), Déirdre Kelly, J. Gallagher, Rory O’Hanlon, Kenneth McDonald, Mark Ledwidge	19
10	Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Shane O’Sullivan, Carlos Medina, Mark Ledwidge, Marek W. Radomski, John F. Gilmer	93
11	Progression of Left Atrial Volume Index in a Population at Risk for Heart Failure: A Substudy of the STOP-HF (St Vincent's Screening to Prevent Heart Failure) Trial 2012 ·European Journal of Heart Failure ·Patrick Collier, Chris Watson, (unknown), Ian Dawkins, Anil Patle, Stephen Horgan, Carmel Conlon, Rory O’Hanlon, John A. Baugh, Mark Ledwidge, Kenneth McDonald	9
12	Are Beta2-Agonists Responsible for Increased Mortality in Heart Failure? 2011 ·European Journal of Heart Failure ·Margaret Bermingham, (unknown), Ian Dawkins, (unknown), (unknown), Kenneth McDonald, Mark Ledwidge	38
13	Can Emerging Biomarkers of Myocardial Remodelling Identify Asymptomatic Hypertensive Patients at Risk for Diastolic Dysfunction and Diastolic Heart Failure? 2011 ·European Journal of Heart Failure ·Patrick Collier, Chris Watson, Victor Voon, Dermot Phelan, (unknown), George Mak, Ramón Martos, John A. Baugh, Mark Ledwidge, Kenneth McDonald	181
14	Diagnosis of Heart Failure with Preserved Ejection Fraction: Improved Accuracy with the Use of Markers of Collagen Turnover 2009 ·European Journal of Heart Failure ·Ramón Martos, John A. Baugh, Mark Ledwidge, Christina O’Loughlin, Niamh Murphy, Carmel Conlon, Anil Patle, Seamas C. Donnelly, Kenneth McDonald	96
15	Outpatient Intravenous Diuretic Therapy; Potential for Marked Reduction in Hospitalisations for Acute Decompensated Heart Failure 2008 ·European Journal of Heart Failure ·Mary Ryder, Niamh Murphy, (unknown), Christina O’Loughlin, Mark Ledwidge, Kenneth McDonald	59
16	Need and Evolution of Need for Device Therapy in a Community Heart Failure Population 2008 ·European Journal of Heart Failure ·(unknown), Christina O’Loughlin, (unknown), Carmel Conlon, Mark Ledwidge, (unknown), Kenneth McDonald	3
17	Improvement but no Cure of Left Ventricular Systolic Dysfunction in Treated Heart Failure Patients 2007 ·European Journal of Heart Failure ·Niamh Murphy, Christina O’Loughlin, Mark Ledwidge, (unknown), Kenneth McDonald	10
18	Heart Failure Care in a Hospital Unit: A Comparison of Standard 3-Month and Extended 6-Month Programs 2005 ·European Journal of Heart Failure ·Mark Ledwidge, Enda Ryan, Christina O’Loughlin, Mary Ryder, Bronagh Travers, (unknown), (unknown), Kenneth McDonald	24
19	Clinical Deterioration in Established Heart Failure: What is the Value of BNP and Weight Gain in Aiding Diagnosis? 2005 ·European Journal of Heart Failure ·(unknown), Mark Ledwidge, Christina O’Loughlin, (unknown), Kenneth McDonald	134
20	Specialist Care of Heart Failure Improves Appropriate Pharmacotherapy at the Expense of Greater Polypharmacy and Drug-Interactions 2004 ·European Journal of Heart Failure ·Mark Ledwidge, Bronagh Travers, Mary Ryder, Enda Ryan, Kenneth McDonald	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact